Supreme Court Weighs Bayer Roundup Cancer Case That Could End 100,000 Lawsuits
The U.S. Supreme Court heard oral arguments in a case brought by Bayer AG concerning its Roundup weedkiller, which faces over 100,000 lawsuits alleging the product causes cancer. At issue is whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-law failure-to-warn claims. A ruling in favor of Bayer could effectively gut the vast majority of pending litigation. The case stems from a lawsuit by a California groundskeeper who developed non-Hodgkin lymphoma after years of using Roundup. The justices' decision, expected by late June, will have major implications for product liability law and the regulation of pesticides.
Key facts
- Supreme Court heard arguments in Bayer's Roundup cancer case
- Case could affect over 100,000 lawsuits against Bayer
- Central question: whether FIFRA preempts state failure-to-warn claims
- Plaintiff is a California groundskeeper with non-Hodgkin lymphoma
- Ruling expected by late June
- Bayer acquired Roundup through its purchase of Monsanto in 2018
- Roundup's active ingredient is glyphosate
- The case is the first Supreme Court review of Roundup litigation
Entities
Institutions
- Bayer AG
- Supreme Court of the United States
- Monsanto
Locations
- United States
- California
Sources
- Quartz —